HbA1c Calculator

Convert your HbA1c (glycated hemoglobin) percentage to estimated average glucose (eAG) in mg/dL or mmol/L.Visualize your result on the ADA risk scale, understand your glycemic control, and get personalized lifestyle insights.

% (NGSP / DCCT)
Enter HbA1c in % (DCCT / NGSP standard) or mmol/mol (IFCC standard). The converter handles both automatically.
? 5.0 % (Normal)
? 6.0 % (Prediabetes)
? 7.0 % (Diabetes – controlled)
? 9.0 % (Diabetes – elevated)
⛔ 10.5 % (High risk)
4.0% 6.0% 8.0% 10.0% 12.0% 14.0%
Your health data stays private: All calculations run locally in your browser. No information is sent to any server. This tool is for educational and informational purposes only.
Medical Disclaimer: This calculator provides estimates for educational purposes. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding your HbA1c results and diabetes management.

Understanding HbA1c and Estimated Average Glucose

Hemoglobin A1c (HbA1c) — often simply called glycated hemoglobin — is a measure of your average blood glucose (blood sugar) levels over the past two to three months. It is formed when glucose in the bloodstream binds irreversibly to hemoglobin in red blood cells. Because red blood cells live for about 120 days, the HbA1c level reflects the average glucose exposure during that period.

The estimated average glucose (eAG) translates the HbA1c percentage into the same units (mg/dL or mmol/L) you see on a daily glucose meter. This makes it easier to connect your A1c result with your everyday monitoring. The conversion formula, validated by the ADAG (A1c-Derived Average Glucose) Study, is:

eAG (mg/dL) = 28.7 × HbA1c (%) – 46.7

or in SI units: eAG (mmol/L) = 1.59 × HbA1c (%) – 2.59

This formula is endorsed by the American Diabetes Association (ADA) and the International Federation of Clinical Chemistry (IFCC). It provides a reliable bridge between the laboratory A1c measurement and the patient's day‑to‑day glucose experience.

Why HbA1c Matters in Diabetes Care

HbA1c is the cornerstone of long‑term glycemic assessment. Unlike finger‑prick tests, which capture a snapshot, HbA1c offers a longitudinal view. This makes it invaluable for:

  • Diagnosis: An HbA1c ≥ 6.5% is diagnostic for diabetes mellitus (ADA criteria).
  • Monitoring: For people with diabetes, an HbA1c ≤ 7.0% is a common treatment target, though goals are individualized.
  • Risk stratification: Levels between 5.7% and 6.4% indicate prediabetes, a high‑risk state for progression to type 2 diabetes.
  • Clinical decision‑making: Trends in HbA1c guide adjustments to medication, diet, and physical activity.

HbA1c Reference Ranges (ADA 2026 Guidelines)

HbA1c (%) HbA1c (mmol/mol) eAG (mg/dL) eAG (mmol/L) Category
< 5.7 < 39 < 117 < 6.5 Normal
5.7 – 6.4 39 – 46 117 – 137 6.5 – 7.6 Prediabetes
6.5 – 7.0 48 – 53 140 – 154 7.8 – 8.6 Diabetes (controlled)
7.1 – 8.0 54 – 64 157 – 183 8.7 – 10.2 Diabetes (moderate)
> 8.0 > 64 > 183 > 10.2 Diabetes (elevated)

Source: American Diabetes Association Standards of Medical Care in Diabetes – 2026. Individual targets may vary based on age, comorbidities, and patient preference.

The Science Behind the eAG Formula

The eAG formula was derived from the landmark ADAG (A1c-Derived Average Glucose) Study, which involved over 500 participants across 10 international centers. Researchers combined continuous glucose monitoring (CGM) data with frequent capillary glucose measurements to establish a robust linear relationship between HbA1c and average glucose. The resulting equation (eAG = 28.7 × A1c – 46.7) has an R² of 0.84, indicating that about 84% of the variability in eAG can be explained by HbA1c.

The IFCC (International Federation of Clinical Chemistry) introduced a reference method for HbA1c measurement that yields results in mmol/mol. The conversion between IFCC and NGSP (%) is: NGSP (%) = 0.0915 × IFCC (mmol/mol) + 2.15. Our calculator seamlessly handles both units, making it accessible to users worldwide.

Clinical Case: Interpreting a 7.2% HbA1c

Case: Mr. T., 58 years old, type 2 diabetes

Mr. T. presents with an HbA1c of 7.2% (55 mmol/mol). Using our calculator, his eAG is approximately 160 mg/dL (8.9 mmol/L). This is above the ADA general target of < 7.0%, indicating that his current therapy (metformin + lifestyle modifications) may need adjustment. However, his age and history of hypoglycemia mean his target is individualized to 7.5%. The calculator's risk interpretation helps Mr. T. understand that while he is in the "diabetes" range, his level is moderate and manageable with intensification of therapy. The visual chart reinforces the relationship between his daily glucose readings and the HbA1c value.

Frequently Asked Questions

The ADA recommends testing HbA1c at least twice a year for people with stable glycemic control, and quarterly (every 3 months) for those whose therapy has changed or who are not meeting treatment goals. For individuals without diabetes, screening is recommended every 3 years starting at age 45, or earlier if risk factors are present.

Daily glucose monitoring (finger‑prick or CGM) gives you a real‑time reading of your blood sugar at a specific moment. HbA1c provides a 2‑ to 3‑month average, smoothing out daily fluctuations. Both are complementary: daily monitoring helps you make immediate decisions (food, exercise, insulin dosing), while HbA1c gives you and your provider a global view of your glycemic control.

Conditions that affect red blood cell turnover (e.g., anemia, hemoglobinopathies, chronic kidney disease, recent blood transfusion) can skew HbA1c results. In such cases, the eAG formula may not be accurate. Your healthcare provider may use alternative markers such as glycated albumin or fructosamine. Always discuss any hematologic conditions with your clinician when interpreting your HbA1c.

For healthy individuals without diabetes, a normal HbA1c is below 5.7% (39 mmol/mol). Levels between 5.7% and 6.4% indicate prediabetes, a condition that carries an increased risk of developing type 2 diabetes, cardiovascular disease, and stroke. Lifestyle interventions (diet, exercise, weight loss) can often reverse prediabetes.

The ADAG study established that the eAG formula has a 95% confidence interval of approximately ± 15 mg/dL around the true average glucose. This means that while the formula is highly reliable for population‑level estimation, individual variations (e.g., in red blood cell lifespan) can cause the actual average glucose to differ slightly. The calculator provides an estimate — always use it alongside clinical judgment.

Evidence‑Based & Clinically Reviewed – This calculator is built on the published ADAG study data and conforms to the ADA and IFCC guidelines for HbA1c reporting. The conversion algorithms are verified against the NGSP (National Glycohemoglobin Standardization Program) reference methods. Content reviewed by Dr. A. Rivera, MD, MPH (endocrinology, 15+ years clinical experience). Last updated July 2026.

References: Nathan DM, Kuenen J, Borg R, et al. (2008) "Translating the A1C Assay Into Estimated Average Glucose Values." Diabetes Care 31(8):1473–1478. Link • ADA Standards of Medical Care in Diabetes – 2026 • IFCC Reference Method for HbA1c.